Spatial characterization and quantification of CD40 expression across cancer types.

Area of Science:

• Immunology
• Oncology

Background:

• CD40, a TNF receptor family member, modulates immune responses.
• CD40 plays a role in both adaptive and innate immunity.

Purpose of the Study:

• To evaluate CD40 expression on tumor cells in lung, ovarian, and pancreatic cancers.
• To investigate the prognostic impact of tumor cell CD40 expression.

Main Methods:

• Quantitative immunofluorescence (QIF) was used to assess CD40 expression.
• Tissue microarrays from nine solid tumor types were initially screened.
• Large patient cohorts of NSCLC, ovarian, and pancreatic cancers were analyzed.

Main Results:

• CD40 expression was common in tumor cells: 80% in NSCLC, 40% in ovarian, and 68% in pancreatic cancer.
• Significant intra-tumoral heterogeneity and partial correlation with stromal CD40 were observed.
• CD40 expression on tumor cells was not prognostic for overall survival in these cancers.

Conclusions:

• High CD40 expression on tumor cells in these cancers warrants consideration for therapeutic targeting.
• The findings support the development of CD40-directed therapies for lung, ovarian, and pancreatic cancers.